Title:
ANTI-CLAUDIN18.2 ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/045997
Kind Code:
A1
Abstract:
Provided are an anti-Claudin18.2 antibody or an antigen binding fragment thereof and a use thereof. Further provided are a bispecific antibody, a multispecific antibody, a multi-functional fusion protein and a composition thereof containing the antibody, and a use in the preparation of a drug for treating cancer.
Inventors:
ZHOU JINHUA (CN)
QIN CHUNLING (CN)
WU CHONGBING (CN)
ZHU CAILIN (CN)
JIANG XIAOLING (CN)
QIN CHUNLING (CN)
WU CHONGBING (CN)
ZHU CAILIN (CN)
JIANG XIAOLING (CN)
Application Number:
PCT/CN2022/120428
Publication Date:
March 30, 2023
Filing Date:
September 22, 2022
Export Citation:
Assignee:
SHENGHE CHINA BIOPHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K19/00; C12N15/13; C12N15/85
Domestic Patent References:
| WO2021130291A1 | 2021-07-01 | |||
| WO2021160155A1 | 2021-08-19 |
Foreign References:
| CN110857322A | 2020-03-03 | |||
| EP3872093A1 | 2021-09-01 | |||
| CN112574307A | 2021-03-30 | |||
| CN104321345A | 2015-01-28 | |||
| CN109762067A | 2019-05-17 |
Download PDF: